Page last updated: 2024-08-23

substance p and Apoplexy

substance p has been researched along with Apoplexy in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (55.00)29.6817
2010's5 (25.00)24.3611
2020's4 (20.00)2.80

Authors

AuthorsStudies
Duan, LH; Liu, QQ; Long, JJ; Wang, CB; Wang, YL; Xiao, P; Zhang, X; Zhang, XH1
Cao, CC; Feng, HY; Lv, HL; Ren, LJ; Wang, YL; Zhang, X; Zhang, XH1
Fritsch, B; Greiner, KL; Hosp, JA; Löffler, F; Martinez Arellano, L; Reis, J; Roth, F1
Bubak, AN; Como, CN; Das, A; Doyle-Meyers, L; Feia, B; Looper, J; Mahalingam, R; Nagel, MA; Pearce, CM; Traina-Dorge, V1
Bittner, S; Claus, I; Dziewas, R; Marian, T; Meuth, SG; Minnerup, J; Muhle, P; Ruck, T; Schröder, JB; Suntrup-Krueger, S; Warnecke, T1
Abo, M; Fujigasaki, H; Hara, T; Hashimoto, G; Ide, T; Niimi, M; Yamada, N1
Gao, Y; Li, J; Li, Y; Su, M1
Almeida, T; Argueso, M; Hernández, M; Lorente, L; Martín, MM; Pérez-Cejas, A; Ramos, L; Riaño-Ruiz, M; Solé-Violán, J1
Hibi, S; Ishii, M; Kume, H; Ouchi, Y; Teramoto, S; Yamaguchi, Y; Yamamoto, H1
Gao, X; Ji, X; Li, L; Luo, Y; Wei, H; Zhao, J1
Abe, A; Katayama, Y; Katsura, K; Nishiyama, Y; Ueda, M1
Arai, T; Fujiwara, H; Sekizawa, K; Yoshimi, N1
Blumbergs, PC; Helps, SC; Rodgers, KM; Sims, NR; Turner, RJ; Vink, R1
Blomstrand, C; Hrafnkelsdóttir, T; Jern, C; Jern, S; Jood, K1
Turner, R; Vink, R2
Barrett, NE; Emerson, M; Gibbins, JM; Hunt, SP; Jones, S; Kaiser, WJ; Lowry, PJ; Sage, T; Tucker, KL; Zimmer, A1
Arai, T; Fujiwara, H; Kashiki, Y; Takaya, T; Toshima, S; Yasuda, Y; Yoshimii, N1
Arai, T; Fujiwara, H; Kashiki, Y; Takaya, T; Toshima, S; Yasuda, Y; Yoshimi, N1
Arai, T; Fujiwara, H; Kashiki, Y; Shibayama, M; Takaya, T; Toshima, S; Yasuda, Y; Yoshimi, N1

Reviews

2 review(s) available for substance p and Apoplexy

ArticleYear
Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke.
    Drug news & perspectives, 2007, Volume: 20, Issue:4

    Topics: Animals; Brain Edema; Brain Ischemia; Encephalitis; Humans; Stroke; Substance P

2007
Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke.
    Timely topics in medicine. Cardiovascular diseases, 2007, Oct-01, Volume: 11

    Topics: Animals; Brain Edema; Brain Injuries; Humans; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Stroke; Substance P

2007

Trials

6 trial(s) available for substance p and Apoplexy

ArticleYear
[Acupuncture with smoothing liver and regulating
    Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2017, Feb-12, Volume: 37, Issue:2

    Topics: Acupuncture Points; Acupuncture Therapy; Constipation; Gastrointestinal Agents; Humans; Lactulose; Liver; Motilin; Qi; Somatostatin; Stroke; Substance P; Treatment Outcome; Vasoactive Intestinal Peptide

2017
Antiplatelet cilostazol, an inhibitor of type III phosphodiesterase, improves swallowing function in patients with a history of stroke.
    Journal of the American Geriatrics Society, 2008, Volume: 56, Issue:6

    Topics: Aged; Aspirin; Cilostazol; Cross-Over Studies; Deglutition Disorders; Double-Blind Method; Humans; Male; Phosphodiesterase Inhibitors; Saliva; Stroke; Substance P; Tetrazoles

2008
Nicergoline increases serum substance P levels in patients with an ischaemic stroke.
    Cerebrovascular diseases (Basel, Switzerland), 2010, Volume: 29, Issue:2

    Topics: Aged; Aged, 80 and over; Basal Ganglia; Biomarkers; Brain Ischemia; Central Nervous System Agents; Deglutition; Female; Humans; Magnetic Resonance Imaging; Male; Nicergoline; Pneumonia, Aspiration; Radioimmunoassay; Stroke; Substance P; Time Factors; Treatment Outcome; Up-Regulation

2010
Serum substance P concentrations and silent aspiration in elderly patients with stroke.
    Neurology, 2003, Dec-09, Volume: 61, Issue:11

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Imidazolidines; Male; Pneumonia, Aspiration; Stroke; Substance P; Treatment Outcome

2003
Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and symptomless dysphagia.
    Chest, 2000, Volume: 117, Issue:6

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Deglutition Disorders; Female; Humans; Hypertension; Imidazoles; Imidazolidines; Losartan; Male; Pneumonia, Aspiration; Stroke; Substance P

2000
Angiotensin II receptor antagonists cannot prevent symptomless dysphagia in hypertensive bedridden older patients with stroke.
    Journal of the American Geriatrics Society, 2000, Volume: 48, Issue:12

    Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Antihypertensive Agents; Bed Rest; Case-Control Studies; Deglutition Disorders; Female; Humans; Hypertension; Losartan; Male; Stroke; Substance P; Treatment Outcome

2000

Other Studies

12 other study(ies) available for substance p and Apoplexy

ArticleYear
Correlation research of serum substance P, CCK-8, and 5-HT values with depression levels in stroke survivors.
    European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:4

    Topics: Cholecystokinin; Humans; Serotonin; Sincalide; Stroke; Substance P; Survivors

2023
An investigation on the changes of serum CCK-8, substance P, and 5-HT in patients with post-stroke insomnia.
    Technology and health care : official journal of the European Society for Engineering and Medicine, 2023, Volume: 31, Issue:6

    Topics: Cholecystokinin; Humans; Serotonin; Sincalide; Sleep Initiation and Maintenance Disorders; Stroke; Substance P

2023
Progressive secondary exo-focal dopaminergic neurodegeneration occurs in not directly connected midbrain nuclei after pure motor-cortical stroke.
    Experimental neurology, 2020, Volume: 327

    Topics: Animals; Dopaminergic Neurons; Male; Mesencephalon; Motor Cortex; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Stroke; Substance P; Substantia Nigra

2020
Elevated serum substance P during simian varicella virus infection in rhesus macaques: implications for chronic inflammation and adverse cerebrovascular events.
    Journal of neurovirology, 2020, Volume: 26, Issue:6

    Topics: Animals; Biomarkers; Gene Expression; Herpesvirus 3, Human; Immunosuppressive Agents; Inflammation; Macaca mulatta; Male; Risk; Stroke; Substance P; Tacrolimus; Varicella Zoster Virus Infection; Virus Activation; Whole-Body Irradiation

2020
Increase of Substance P Concentration in Saliva after Pharyngeal Electrical Stimulation in Severely Dysphagic Stroke Patients - an Indicator of Decannulation Success?
    Neuro-Signals, 2017, Volume: 25, Issue:1

    Topics: Aged; Aged, 80 and over; Deglutition Disorders; Electric Stimulation; Female; Humans; Male; Middle Aged; Pharynx; Prospective Studies; Saliva; Stroke; Substance P; Tracheostomy

2017
Relationship Between Frequency of Spontaneous Swallowing and Salivary Substance P Level in Patients with Acute Stroke.
    Dysphagia, 2018, Volume: 33, Issue:4

    Topics: Aged; Cough; Deglutition; Female; Humans; Male; Middle Aged; Saliva; Stroke; Substance P

2018
Serum Levels of Substance P and Mortality in Patients with a Severe Acute Ischemic Stroke.
    International journal of molecular sciences, 2016, Jun-22, Volume: 17, Issue:6

    Topics: Aged; Biomarkers; Female; Glasgow Coma Scale; Humans; Infarction, Middle Cerebral Artery; Male; Middle Aged; Stroke; Substance P; Survival Rate

2016
Plasma and cerebrospinal fluid substance P in post-stroke patients with depression.
    Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Brain; Depression; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Stroke; Substance P

2009
Increased substance P immunoreactivity and edema formation following reversible ischemic stroke.
    Acta neurochirurgica. Supplement, 2006, Volume: 96

    Topics: Animals; Brain Edema; Cerebral Cortex; Inflammation Mediators; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke; Substance P

2006
Local tissue-type plasminogen activator release in patients with ischemic stroke.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:6

    Topics: Brachial Artery; Brain Ischemia; Case-Control Studies; Forearm; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Stroke; Substance P; Tissue Plasminogen Activator

2007
Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation.
    Blood, 2008, Jan-15, Volume: 111, Issue:2

    Topics: Animals; Bleeding Time; Blood Flow Velocity; Blood Platelets; Hemostasis; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Myocardial Infarction; Platelet Activation; Receptors, Neurokinin-1; Stroke; Substance P; Thromboembolism

2008
Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, and pneumonia in elderly hypertensive patients with stroke.
    Chest, 2001, Volume: 119, Issue:2

    Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Pneumonia; Stroke; Substance P

2001